http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021085936-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c0e49ed6fbd514aa5d070bbfafeae8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7adde5f00da37ebcefd79d76ee584da3
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2027-004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0464
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-006
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00
filingDate 2020-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff0d952df548774cb1b3160ef2fe2b3e
publicationDate 2021-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021085936-A1
titleOfInvention Cerebrospinal fluid diversion for the treatment of chronic fatigue syndrome and fibromyalgia and use of rnfl thinning as a biomarker therefor
abstract This application discloses methods and tools for the treatment of chronic fatigue syndrome (CFS) and fibromyalgia and the use of retinal nerve fiber layer thinning as a biomarker for the treatment.
priorityDate 2019-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID383689
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25293
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PEB5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395645
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A2R8Q5A8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281008
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID383689

Total number of triples: 25.